210 related articles for article (PubMed ID: 19728388)
1. Adalimumab for cutaneous metastatic Crohn's disease.
Cury DB; Moss AC; Elias G; Nakao A
Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388
[No Abstract] [Full Text] [Related]
2. Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies.
Malesci A; Angelucci E; Bonifacio C; Sociale O; Omodei P; Repici A; Balzarini L; Danese S
Inflamm Bowel Dis; 2009 Jun; 15(6):814-5. PubMed ID: 18831523
[No Abstract] [Full Text] [Related]
3. Successful use of adalimumab in treating cutaneous metastatic Crohn's disease: report of a case.
Miller FA; Jones CR; Clarke LE; Lin Z; Adams DR; Koltun WA
Inflamm Bowel Dis; 2009 Nov; 15(11):1611-2. PubMed ID: 19090557
[No Abstract] [Full Text] [Related]
4. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab.
Lestre S; Ramos J; João A; Serrão V
Eur J Dermatol; 2010; 20(4):504-5. PubMed ID: 20507839
[No Abstract] [Full Text] [Related]
5. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.
Jürgens M; Brand S; Filik L; Hübener C; Hasbargen U; Beigel F; Tillack C; Göke B; Ochsenkühn T; Seiderer J
Inflamm Bowel Dis; 2010 Oct; 16(10):1634-6. PubMed ID: 20027647
[No Abstract] [Full Text] [Related]
6. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic Crohn's disease. Response to adalimumab dose intensification].
Lázaro Saéz M; Hernández Martínez A; Bendezú García RÁ; Rodríguez Manrique MA; Simón López F; Medina Estévez E; Vega Sáenz JL
Gastroenterol Hepatol; 2012 May; 35(5):321-5. PubMed ID: 22445940
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab as therapy for fistulizing orofacial Crohn's disease.
Doherty G; Kalachand R; Patchett S
Inflamm Bowel Dis; 2010 Feb; 16(2):184-5. PubMed ID: 19408321
[No Abstract] [Full Text] [Related]
9. Esophageal Crohn's disease treated successfully with adalimumab.
Kwan LY; Conklin JL; Papadakis KA
Inflamm Bowel Dis; 2007 May; 13(5):639-40. PubMed ID: 17221856
[No Abstract] [Full Text] [Related]
10. Fulminant Crohn's colitis: when only an antibody will do.
Ng SC; Kamm MA
Inflamm Bowel Dis; 2007 Aug; 13(8):971-4. PubMed ID: 17427240
[TBL] [Abstract][Full Text] [Related]
11. [Adalimumab therapy in Crohn's disdease].
Baryshnikov EN; Lazebnik LB; Parfenov AI
Eksp Klin Gastroenterol; 2009; (5):92-8. PubMed ID: 20205331
[TBL] [Abstract][Full Text] [Related]
12. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.
Mishkin DS; Van Deinse W; Becker JM; Farraye FA
Inflamm Bowel Dis; 2006 Aug; 12(8):827-8. PubMed ID: 16917239
[No Abstract] [Full Text] [Related]
13. Commentary: infliximab or adalimumab in Crohn's disease?
Sprakes MB; Hamlin PJ
Aliment Pharmacol Ther; 2012 Aug; 36(4):398. PubMed ID: 22803644
[No Abstract] [Full Text] [Related]
14. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
Absah I; Faubion WA
Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
[TBL] [Abstract][Full Text] [Related]
15. Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
Lopez-Sanroman A; Gisbert JP
Aliment Pharmacol Ther; 2012 Sep; 36(5):498-9. PubMed ID: 22860615
[No Abstract] [Full Text] [Related]
16. [Adalimumab in Crohn's disease - data from real life].
López San Román A; Van Domselaar M; Garrido E
Rev Esp Enferm Dig; 2008 Nov; 100(11):671-5. PubMed ID: 19159169
[No Abstract] [Full Text] [Related]
17. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
Lazebnik LB; Sagynbaeva VÉ
Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
[TBL] [Abstract][Full Text] [Related]
18. [Oligosymptomatic alimentary tract perforation in course of Crohn's disease in patient treated with anti-TNF alfa antibodies].
Jałocha Ł; Wojtuń S; Wojtkowiak M; Błaszak A; Dyrla P; Gil J
Pol Merkur Lekarski; 2009 May; 26(155):491-2. PubMed ID: 19606707
[TBL] [Abstract][Full Text] [Related]
19. Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
Tursi A; Elisei W; Picchio M; Penna A
Aliment Pharmacol Ther; 2013 Apr; 37(7):763-4. PubMed ID: 23458543
[No Abstract] [Full Text] [Related]
20. Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab.
Nancey S; Boschetti G; Cotte E; Cathey-Javouhay A; Laidet M; Chichery A; Francois Y; Glehen O; Flourié B
Inflamm Bowel Dis; 2011 Apr; 17(4):1060-1. PubMed ID: 21391289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
